AU2002364705A1 - Antisense modulation of protein expression - Google Patents

Antisense modulation of protein expression

Info

Publication number: AU2002364705A1
Authority: AU; Australia
Prior art keywords: protein expression; antisense modulation; antisense; modulation; protein
Prior art date: 2001-11-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002364705A

Other languages

English (en)

Other versions

AU2002364705A8 (en

Inventor

John S. Chant

Chunli Huang

Jingfang Ju

Isabelle Millet

John A. Peyman

Jan Fredik Simons

Glennda Smithson

Bruce E. Taillon

Haihong Zhong

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CuraGen Corp

Original Assignee

CuraGen Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-29

Filing date

2002-11-27

Publication date

2003-09-09

2002-04-02 Priority claimed from US10/114,153 external-priority patent/US20030185815A1/en

2002-04-02 Priority claimed from US10/114,270 external-priority patent/US7033790B2/en

2002-11-27 Application filed by CuraGen Corp filed Critical CuraGen Corp

2003-09-09 Publication of AU2002364705A8 publication Critical patent/AU2002364705A8/xx

2003-09-09 Publication of AU2002364705A1 publication Critical patent/AU2002364705A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/0115—N-Acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (2.4.1.150)

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Virology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002364705A 2001-11-29 2002-11-27 Antisense modulation of protein expression Abandoned AU2002364705A1 (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US33414801P	2001-11-29	2001-11-29
US60/334,148		2001-11-29
US33657201P	2001-12-04	2001-12-04
US60/336,572		2001-12-04
US10/114,153		2002-04-02
US10/114,153 US20030185815A1 (en)	2001-04-03	2002-04-02	Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
US10/114,270 US7033790B2 (en)	2001-04-03	2002-04-02	Proteins and nucleic acids encoding same
US10/114,270		2002-04-02
US13682602A	2002-05-01	2002-05-01
US10/136,826		2002-05-01
PCT/US2002/038188 WO2003070160A2 (fr)	2001-11-29	2002-11-27	Modulation antisens d'expression de proteine

Publications (2)

Publication Number	Publication Date
AU2002364705A8 AU2002364705A8 (en)	2003-09-09
AU2002364705A1 true AU2002364705A1 (en)	2003-09-09

Family

ID=31499636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002364705A Abandoned AU2002364705A1 (en)	2001-11-29	2002-11-27	Antisense modulation of protein expression

Country Status (2)

Country	Link
AU (1)	AU2002364705A1 (fr)
WO (1)	WO2003070160A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1558737A4 (fr) *	2002-10-18	2008-06-11	Lg Life Sciences Ltd	Familles de genes associes a des cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6653448B1 (en) *	2000-03-29	2003-11-25	Curagen Corporation	Wnt-7B-like polypeptides and nucleic acids encoding same
US7413873B2 (en) *	2001-01-30	2008-08-19	The Regents Of The University Of California	Method of detection and treatment of colon cancer

2002
- 2002-11-27 AU AU2002364705A patent/AU2002364705A1/en not_active Abandoned
- 2002-11-27 WO PCT/US2002/038188 patent/WO2003070160A2/fr not_active Ceased

Also Published As

Publication number	Publication date
AU2002364705A8 (en)	2003-09-09
WO2003070160A3 (fr)	2004-02-12
WO2003070160A2 (fr)	2003-08-28

Publication	Publication Date	Title
AU2001289085A1 (en)	2002-04-02	Antisense modulation of flip-c expression
AU2002316698A1 (en)	2003-03-03	Antisense modulation of bcl2-associated x protein expression
AU2002364125A1 (en)	2003-06-17	Antisense modulation of mdm2 expression
AU2002343356A1 (en)	2003-03-24	Antisense modulation of protein kinase r expression
AU2002350228A1 (en)	2003-06-10	Antisense modulation of myd88 expression
AU2002366788A1 (en)	2003-07-09	Antisense modulation of ship-1 expression
AU2002320525A1 (en)	2003-03-03	Antisense modulation of glioma-associated oncogene-2 expression
AU2001227847A1 (en)	2001-07-31	Antisense modulation of pepck-cytosolic expression
AU2002318139A1 (en)	2002-12-03	Antisense modulation of src-c expression
AU2001285302A1 (en)	2002-03-22	Antisense modulation of ubiquitin protein ligase expression
AU2003239579A1 (en)	2003-12-31	Antisense modulation of vegf-c expression
AU2002357102A1 (en)	2003-06-30	Antisense modulation of cd36l1 expression
AU2003257966A1 (en)	2004-02-16	Antisense modulation of lar expression
AU2002322551A1 (en)	2003-04-07	Antisense modulation of rip2 expression
AU2002347809A1 (en)	2003-04-22	Antisense modulation of inhibitor-kappa b kinase-gamma expression
AU2002245089A1 (en)	2002-07-24	Antisense modulation of cytohesin-1 expression
AU2002357101A1 (en)	2003-07-09	Antisense modulation of cd81 expression
AU2003241496A1 (en)	2003-12-12	Antisense modulation of inhibitor-kappa b kinase-beta expression
AU2002364705A1 (en)	2003-09-09	Antisense modulation of protein expression
AU2002334599A1 (en)	2003-04-01	Antisense modulation of ksr expression
AU2002244086A1 (en)	2002-09-12	Antisense modulation of recql4 expression
AU2002350042A1 (en)	2003-05-12	Antisense modulation of phospholipase a2 group v expression
AU2002362139A1 (en)	2003-06-30	Antisense modulation of b-cell associated protein expression
AU2002315554A1 (en)	2003-03-03	Antisense modulation of glioma-associated oncogene-3 expression
AU2002353026A1 (en)	2003-06-23	Antisense modulation of nod1 expression

Legal Events

Date	Code	Title	Description
2004-03-25	TH	Corrigenda	Free format text: IN VOL 17, NO 31, PAGE(S) 11103 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN, PATENTS CEASED OR EXPIRED - 2002 DELETE ALL REFERENCE TO 2002364705
2004-08-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase